- Home
- SQNS vs MNOV Comparison
SQNS vs MNOV Comparison
Compare SQNS & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- MNOV
- Stock Information
- Founded
- SQNS 2003
- MNOV 2000
- Country
- SQNS France
- MNOV United States
- Employees
- SQNS N/A
- MNOV N/A
- Industry
- SQNS Semiconductors
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- MNOV Health Care
- Exchange
- SQNS Nasdaq
- MNOV Nasdaq
- Market Cap
- SQNS 85.7M
- MNOV 76.0M
- IPO Year
- SQNS 2011
- MNOV 2005
- Fundamental
- Price
- SQNS $2.10
- MNOV $1.41
- Analyst Decision
- SQNS Strong Buy
- MNOV Strong Buy
- Analyst Count
- SQNS 1
- MNOV 1
- Target Price
- SQNS $7.50
- MNOV $9.00
- AVG Volume (30 Days)
- SQNS 64.5K
- MNOV 13.2K
- Earning Date
- SQNS 02-11-2025
- MNOV 05-08-2025
- Dividend Yield
- SQNS N/A
- MNOV N/A
- EPS Growth
- SQNS N/A
- MNOV N/A
- EPS
- SQNS 2.00
- MNOV N/A
- Revenue
- SQNS $36,762,000.00
- MNOV N/A
- Revenue This Year
- SQNS N/A
- MNOV N/A
- Revenue Next Year
- SQNS $95.51
- MNOV N/A
- P/E Ratio
- SQNS $1.05
- MNOV N/A
- Revenue Growth
- SQNS 9.36
- MNOV N/A
- 52 Week Low
- SQNS $0.95
- MNOV $1.12
- 52 Week High
- SQNS $4.28
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- SQNS 34.22
- MNOV 33.27
- Support Level
- SQNS $2.10
- MNOV $1.44
- Resistance Level
- SQNS $2.49
- MNOV $1.53
- Average True Range (ATR)
- SQNS 0.14
- MNOV 0.05
- MACD
- SQNS 0.00
- MNOV 0.01
- Stochastic Oscillator
- SQNS 17.02
- MNOV 0.00
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.